Common Cardiovascular Risk Factors and In-hospital Mortality in 3,894 Patients with COVID-19: Survival Analysis and Machine Learning-based Findings from the Multicentre Italian CORIST Study
Overview
Authors
Affiliations
Background And Aims: There is poor knowledge on characteristics, comorbidities and laboratory measures associated with risk for adverse outcomes and in-hospital mortality in European Countries. We aimed at identifying baseline characteristics predisposing COVID-19 patients to in-hospital death.
Methods And Results: Retrospective observational study on 3894 patients with SARS-CoV-2 infection hospitalized from February 19th to May 23rd, 2020 and recruited in 30 clinical centres distributed throughout Italy. Machine learning (random forest)-based and Cox survival analysis. 61.7% of participants were men (median age 67 years), followed up for a median of 13 days. In-hospital mortality exhibited a geographical gradient, Northern Italian regions featuring more than twofold higher death rates as compared to Central/Southern areas (15.6% vs 6.4%, respectively). Machine learning analysis revealed that the most important features in death classification were impaired renal function, elevated C reactive protein and advanced age. These findings were confirmed by multivariable Cox survival analysis (hazard ratio (HR): 8.2; 95% confidence interval (CI) 4.6-14.7 for age ≥85 vs 18-44 y); HR = 4.7; 2.9-7.7 for estimated glomerular filtration rate levels <15 vs ≥ 90 mL/min/1.73 m; HR = 2.3; 1.5-3.6 for C-reactive protein levels ≥10 vs ≤ 3 mg/L). No relation was found with obesity, tobacco use, cardiovascular disease and related-comorbidities. The associations between these variables and mortality were substantially homogenous across all sub-groups analyses.
Conclusions: Impaired renal function, elevated C-reactive protein and advanced age were major predictors of in-hospital death in a large cohort of unselected patients with COVID-19, admitted to 30 different clinical centres all over Italy.
Gonzalez Rodriguez J, Oprescu A, Munoz Lezcano S, Cordero Ramos J, Romero Cabrera J, Armengol de la Hoz M Front Public Health. 2024; 12:1437388.
PMID: 39624415 PMC: 11609198. DOI: 10.3389/fpubh.2024.1437388.
Mapelli M, Salvioni E, Mattavelli I, Banfi C, Ghilardi S, Greco A ERJ Open Res. 2024; 10(6).
PMID: 39588076 PMC: 11587118. DOI: 10.1183/23120541.00301-2024.
Sokolski M, Trenson S, Reszka K, Urban S, Sokolska J, Biering-Sorensen T Cardiol J. 2024; 31(4):512-521.
PMID: 38832553 PMC: 11374323. DOI: 10.5603/cj.98489.
Seyedtabib M, Najafi-Vosough R, Kamyari N BMC Infect Dis. 2024; 24(1):411.
PMID: 38637727 PMC: 11025285. DOI: 10.1186/s12879-024-09298-w.
Sila T, Suriyaamorn W, Toh C, Rajborirug S, Surasombatpattana S, Thongsuksai P Front Public Health. 2024; 12:1350304.
PMID: 38572011 PMC: 10987961. DOI: 10.3389/fpubh.2024.1350304.